[1]
Żaneta Kimber-Trojnar, “Clinical profiles of women in whom it is worth to consider oral contraceptives containing drospirenone and ethinyl estradiol”, J EBM, vol. 10, no. 1(34), pp. 60-62, Mar. 2017.